Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

93.17USD
15 Dec 2017
Change (% chg)

$3.86 (+4.32%)
Prev Close
$89.31
Open
$91.74
Day's High
$94.06
Day's Low
$90.90
Volume
1,228,616
Avg. Vol
437,953
52-wk High
$97.85
52-wk Low
$71.90

Chart for

About

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $17,634.10
Shares Outstanding(Mil.): 219.11
Dividend: 0.37
Yield (%): 1.81

Financials

  Industry Sector
P/E (TTM): -- 21.41 16.44
EPS (TTM): -- -- --
ROI: -- 11.88 10.62
ROE: -- 13.57 14.20

BRIEF-AmerisourceBergen Announces Operating Commitments to Address Opioid Diversion And Abuse

* AMERISOURCEBERGEN ANNOUNCES OPERATING COMMITMENTS TO ADDRESS OPIOID DIVERSION AND ABUSE

07 Dec 2017

Fitch Rates AmerisourceBergen's Senior Notes 'A-'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, December 05 (Fitch) Fitch Ratings has assigned an 'A-' rating to AmerisourceBergen's (ABC) sale of $750 million senior notes due 2027 and $500 million senior notes due 2047. Proceeds are expected to be used to finance the acquisition of H.D. Smith for $815 million in cash and to redeem 4.875% senior notes due Nov. 15, 2019, and for general corporate purposes. See key terms of the notes below the list of rating actions. Fitch h

06 Dec 2017

BRIEF-AmerisourceBergen Prices $750 Mln 3.45 Pct Senior Notes Due 2027

* AMERISOURCEBERGEN PRICES $750 MILLION 3.45% SENIOR NOTES DUE 2027 AND $500 MILLION 4.30% SENIOR NOTES DUE 2047 Source text for Eikon: Further company coverage:

30 Nov 2017

AmerisourceBergen to pay $625 million to settle U.S. government probe

A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.

22 Nov 2017

UPDATE 1-AmerisourceBergen to pay $625 mln to settle U.S. government probe

Nov 21 A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.

22 Nov 2017

AmerisourceBergen to pay $625 mln to settle U.S. government probe

Nov 21 A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe into its pre-filled syringe program, the company said in a filing with U.S. securities regulators on Tuesday.

22 Nov 2017

AmerisourceBergen to buy drug wholesaler H.D. Smith for $815 mln

AmerisourceBergen Corp said on Monday it would buy privately held U.S. drug wholesaler H. D. Smith for $815 million in cash.

21 Nov 2017

AmerisourceBergen to buy drug wholesaler H.D. Smith for $815 mln

Nov 20 AmerisourceBergen Corp said on Monday it would buy privately held U.S. drug wholesaler H. D. Smith for $815 million in cash.

21 Nov 2017

BRIEF-AmerisourceBergen to acquire H. D. Smith

* AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​

21 Nov 2017

AmerisourceBergen expects tumbling generic drug prices to settle

AmerisourceBergen Corp said it expects stubbornly low generic drug prices, which have plagued drugmakers and wholesalers, to not deteriorate further next year, and brushed off concerns about Amazon's possible entry into the industry.

02 Nov 2017

Competitors

Earnings vs. Estimates